The Peterson-KFF Health System Tracker provides clear, up-to-date information on trends, drivers and issues that impact the performance of the system. It also illustrates how the U.S. is performing relative to other countries and how different parts of the system are performing relative to one another. A partnership of the Peterson Center on Healthcare and the KFF, the Tracker’s work goal places a heavy emphasis on data and evidence, addressing key questions through collections of charts, which provide data with additional context and synthesis of the latest research and developments. The Tracker also provide regular insight briefs for a more in-depth look at topical questions.
Featured Peterson-KFF Resources
Unvaccinated COVID patients cost the U.S. health system billions of dollars
This updated analysis for the Peterson-KFF Health System Tracker estimates that the preventable costs of treating unvaccinated patients in hospitals total $3.7 billion in August, almost twice the estimates for June and July combined. The three-month total now stand at an estimated $5.7 billion.
Issue Brief See More
Related Peterson-KFF Resources
- National Health Spending Explorer
- COVID-19 continues to be a leading cause of death in the U.S. in August 2021
- Early 2021 Data Show No Rebound in Health Care Utilization
- Few Adults Are Aware of Hospital Price Transparency Requirements
- Early Results from Federal Price Transparency Rule Show Difficultly in Estimating the Cost of Care
- Surprise Bills Vary by Diagnosis and Type of Admission
- Health System Dashboard
- Household Health Spending Calculator
- What Do We Know About People with High Out-of-Pocket Spending?
- What Drives Health Spending in the U.S. Compared to Other Countries
- How does the quality of the U.S. health care system compare to other countries?
Most private insurers are no longer waiving cost-sharing for COVID-19 treatment
This analysis finds nearly three quarters of the largest health plans in each state are no longer waiving enrollees’ cost-sharing requirements for COVID-19 treatment as of August 2021. Insurers largely waived those costs early in the pandemic, before safe and effetive vaccines were available.
Issue Brief See More
Refine Results
- view as grid
- view as list
Where Do Americans Get Vaccines and How Much Does It Cost to Administer Them?
A new issue brief shows where Americans typically get flu vaccines in the U.S. and how much it costs to administer flu and other vaccines. Among the analysis’ findings: while most people get flu vaccines at a doctor’s office or retail health clinic, White people are more likely than Black,…
Issue Brief Read More
Analysis Examines the Implications of Price Transparency for Providers and Patients as New Rules Go into Effect
A new KFF analysis examines how new federal rules on price transparency for health services may affect patient decision-making and market pricing. As of January 1, 2021, the United States Department of Health and Human Services requires that hospitals publish payer-negotiated rates for common services on their websites. A second…
News Release Read More
Price Transparency and Price Variation in U.S. Health Services
A new Peterson-KFF analysis examines the potential impact of new federal price transparency rules on patient decision-making and market pricing for health services. The brief also includes new analysis of geographic variation in health prices.
Issue Brief Read More
National Health Spending Explorer
The Health Spending Explorer on the Peterson-KFF Health System Tracker helps users examine five decades worth of numbers documenting expenditures by federal and local governments, private insurers, and individuals on 15 categories of health services, including hospitals, physician and clinic care, and prescription drugs.
Interactive Read More
Health System Dashboard
The Peterson-KFF Health System Dashboard examines the U.S. health system’s performance in four areas: access and affordability, health and well-being, health spending, and quality of care. Users can explore trends over time, as well as disparities and differences across demographic groups.
Interactive Read More
Cost-Sharing Waivers and Premium Relief by Private Plans in Response to COVID-19 (Nov. 2020 Update)
An updated issue brief estimates the number of enrollees in individual and fully-insured group market plans that have waived cost-sharing – out-of-pocket costs including coinsurance, copayments, and deductibles – for COVID-19 treatment. The analysis also estimates the number of enrollees whose insurer is offering various forms of premium payment relief.…
Issue Brief Read More
Analysis: COVID-19 Ranks as a Top 3 Leading Cause of Death in the U.S., Higher than in Almost All Other Peer Countries
A new KFF analysis examines leading causes of death and mortality rates in the United States and comparable countries. The U.S. has a higher COVID-19 mortality rate than many of its peer countries, with COVID-19 ranking as the nation’s third-leading cause of death in 2020, behind only heart disease and…
News Release Read More